Tctc Holdings, LLC Pfizer Inc Transaction History

Tctc Holdings, LLC

  • $2.88 Billion
  • Q3 2024

A detailed history of Tctc Holdings, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Tctc Holdings, LLC holds 1,349,889 shares of PFE stock, worth $33.7 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
1,349,889
Previous 1,344,977 0.37%
Holding current value
$33.7 Million
Previous $37.6 Million 3.81%
% of portfolio
1.36%
Previous 1.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$27.7 - $31.39 $136,062 - $154,187
4,912 Added 0.37%
1,349,889 $39.1 Million
Q2 2024

Aug 05, 2024
BUY
$25.26 - $29.6 $2.02 Million - $2.37 Million
79,958 Added 6.32%
1,344,977 $37.6 Million
Q1 2024

May 09, 2024
BUY
$25.89 - $29.73 $4.18 Million - $4.8 Million
161,535 Added 14.64%
1,265,019 $35.1 Million
Q4 2023

Feb 08, 2024
BUY
$26.13 - $33.94 $662,813 - $860,922
25,366 Added 2.35%
1,103,484 $31.8 Million
Q3 2023

Nov 13, 2023
SELL
$32.09 - $37.51 $305,240 - $356,795
-9,512 Reduced 0.87%
1,078,118 $35.8 Million
Q2 2023

Aug 10, 2023
BUY
$36.12 - $41.79 $151,740 - $175,559
4,201 Added 0.39%
1,087,630 $39.9 Million
Q1 2023

May 12, 2023
BUY
$39.39 - $51.28 $427,105 - $556,029
10,843 Added 1.01%
1,083,429 $44.2 Million
Q4 2022

Feb 10, 2023
BUY
$41.75 - $54.5 $12,859 - $16,786
308 Added 0.03%
1,072,586 $55 Million
Q3 2022

Nov 09, 2022
BUY
$43.76 - $53.42 $52,512 - $64,104
1,200 Added 0.11%
1,072,278 $46.9 Million
Q2 2022

Aug 11, 2022
SELL
$46.53 - $55.17 $7,305 - $8,661
-157 Reduced 0.01%
1,071,078 $56.2 Million
Q1 2022

May 11, 2022
SELL
$45.75 - $56.69 $303,825 - $376,478
-6,641 Reduced 0.62%
1,071,235 $55.5 Million
Q4 2021

Feb 09, 2022
SELL
$41.32 - $61.25 $39,956 - $59,228
-967 Reduced 0.09%
1,077,876 $63.6 Million
Q3 2021

Nov 04, 2021
SELL
$39.25 - $50.42 $177,253 - $227,696
-4,516 Reduced 0.42%
1,078,843 $46.4 Million
Q2 2021

Aug 11, 2021
SELL
$35.91 - $40.68 $582,962 - $660,399
-16,234 Reduced 1.48%
1,083,359 $42.4 Million
Q1 2021

May 12, 2021
SELL
$33.49 - $37.77 $28,265 - $31,877
-844 Reduced 0.08%
1,099,593 $39.8 Million
Q4 2020

Feb 10, 2021
SELL
$33.47 - $42.56 $65,333 - $83,077
-1,952 Reduced 0.18%
1,100,437 $40.5 Million
Q3 2020

Nov 12, 2020
BUY
$31.75 - $37.25 $135,413 - $158,871
4,265 Added 0.39%
1,102,389 $40.5 Million
Q2 2020

Aug 12, 2020
BUY
$30.12 - $36.54 $233,339 - $283,075
7,747 Added 0.71%
1,098,124 $35.9 Million
Q1 2020

May 12, 2020
SELL
$27.03 - $38.62 $24,867 - $35,530
-920 Reduced 0.08%
1,090,377 $35.6 Million
Q3 2019

Nov 13, 2019
SELL
$32.49 - $42.13 $63,160 - $81,900
-1,944 Reduced 0.18%
1,091,297 $39.2 Million
Q2 2019

Aug 14, 2019
SELL
$36.98 - $41.52 $183,753 - $206,312
-4,969 Reduced 0.45%
1,093,241 $47.4 Million
Q1 2019

May 15, 2019
SELL
$37.5 - $41.2 $3,675 - $4,037
-98 Reduced 0.01%
1,098,210 $46.6 Million
Q4 2018

Feb 14, 2019
BUY
$38.47 - $43.86 $17,580 - $20,044
457 Added 0.04%
1,098,308 $47.9 Million
Q3 2018

Nov 14, 2018
SELL
$34.47 - $41.81 $122,368 - $148,425
-3,550 Reduced 0.32%
1,097,851 $48.4 Million
Q2 2018

Aug 14, 2018
SELL
$32.98 - $35.16 $41,224 - $43,949
-1,250 Reduced 0.11%
1,101,401 $40 Million
Q1 2018

May 15, 2018
BUY
$31.91 - $37.02 $1.86 Million - $2.16 Million
58,428 Added 5.6%
1,102,651 $39.1 Million
Q4 2017

Feb 14, 2018
SELL
$33.26 - $35.29 $83,150 - $88,225
-2,500 Reduced 0.24%
1,044,223 $37.8 Million
Q3 2017

Nov 14, 2017
BUY
$31.0 - $34.15 $9,331 - $10,279
301 Added 0.03%
1,046,723 $37.4 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,046,422
1,046,422 $35.1 Million

Others Institutions Holding PFE

# of Institutions
3,256
Shares Held
3.62B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Tctc Holdings, LLC Portfolio

Follow Tctc Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email